source
- Supreme Court rules generic maker Hikma does not infringe Amarin patents, easing skinny-label lawsuitsThe U.S. Supreme Court issued a unanimous decision that Hikma Pharmaceuticals did not violate patents owned by Amarin. The high court overturned a lower court ruling that had favored the brand name…
- Dimension Capital targets up to $750M for third life-sciences fund after strong portfolio performanceDimension Capital, a New York and San Francisco-based investment firm that blends machine learning with life-science ventures, announced it is launching its third fund. The firm is seeking up to $…